Table 1.
Disease model | Genetic Intervention in mice | Results | Ref |
---|---|---|---|
Aging | Atg5 transgene (Tg) overexpression | Reduced age-related cardiac fibrosis, increased lifespan extension | (Pyo et al., 2013) |
BECN1F121A knockin | Reduced age-associated cardiac alterations, increased lifespan | (Fernández et al., 2018) | |
Prkn Tg overexpression | Reduced age-associated cardiac abnormalities | (Hoshino et al., 2013) | |
Atherosclerosis | atg5 −/− | Accelerated atherosclerosis | (Liao et al., 2012b) |
Cardiomyopathy | Atg5 +/− | Exacerbated cardiac hypertrophy | (Zhao et al., 2014) |
Atg7 Tg overexpression | Reduced cardiac hypertrophy, limited intracellular protein aggregation, and increased mouse survival | (Bhuiyan et al., 2013) | |
Becn1 +/− | Accelerated heart failure | (Tannous et al., 2008) | |
Becnl Tg overexpression | Exacerbated pathogenic remodeling | (Zhu et al., 2007) | |
Myocardial infarction | Becn1 +/− | Reduced cardiac damage at reperfusion | (Matsui et al., 2007) |
prkn
−/−
prkn −/− |
Exacerbated cardiac injury and reduced survival Increased infarct size, hypertrophy |
(Kubli et al., 2013) | |
atg5 −/− | Increased sensitivity, exacerbated hypertrophy | (Nakai et al., 2007) | |
I/R injury | Becn1 +/− | Cardioprotective during reperfusion | (Matsui et al., 2007) |
Pressure overload | atg5 −/− | Increased sensitivity, exacerbated hypertrophy | (Nakai et al., 2007) |
Becn1+/− Becn1 Tg overexpression |
Reduced pathological cardiac remodeling Exacerbated pathological cardiac remodeling |
(Zhu et al., 2007) | |
Sepsis | Becn1 +/− | Cardioprotective during reperfusion | (Sun et al., 2018) |